TriArm Therapeutics Appoints Douglas E. Williams, Ph.D., as Chief Executive Officer

SAN MATEO, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) — TriArm Therapeutics (“TriArm” or the “Company”), a clinical-stage, next-generation cell …

Do you trust this headline?

Based on recent headline ratings, 82% of this readership currently trusts the local media, which has an average score of 82% regionally and is currently trending positiveneutrally.

82%

Media Trust Score82%